Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study
Titel:
Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study
Auteur:
Tempero, M. Oh, D.-Y. Tabernero, J. Reni, M. Van Cutsem, E. Hendifar, A. Waldschmidt, D.-T. Starling, N. Bachet, J.-B. Chang, H.-M. Maurel, J. Garcia-Carbonero, R. Lonardi, S. Coussens, L.M. Fong, L. Tsao, L.C. Cole Jr, G. James, D. Macarulla, T.